Tilson Financial Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,500
Closed -$246K 82
2025
Q4
$246K Hold
1,500
0.08% 78
2025
Q3
$201K Buy
+1,500
New +$182K 0.07% 77
2025
Q1
Sell
-1,500
Closed -$216K 75
2024
Q4
$216K Hold
1,500
0.09% 71
2024
Q3
$223K Buy
+1,500
New +$215K 0.1% 70
2024
Q2
Sell
-1,500
Closed -$276K 58
2024
Q1
$276K Hold
1,500
0.15% 59
2023
Q4
$270K Hold
1,500
0.17% 56
2023
Q3
$239K Buy
+1,500
New +$245K 0.19% 56
2023
Q2
Sell
-1,500
Closed -$253K 50
2023
Q1
$253K Hold
1,500
0.21% 53
2022
Q4
$254K Buy
+1,500
New +$272K 0.22% 53

Other funds holding RGEN

Tilson Financial Group's RGEN Position: Q1 2026 in Review

Tilson Financial Group sold out of Repligen (RGEN) in Q1 2026, closing a stake of 1,500 shares — an estimated $246K sold.

Tilson Financial Group first reported a position in RGEN in Q4 2022 and held it in 9 quarters. The position peaked at $276K in Q1 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Tilson Financial Group reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Tilson Financial Group sold 1,500 Repligen shares in Q1 2026, an estimated $246K.
  • Tilson Financial Group first reported a position in Repligen in Q4 2022 and held it in 9 quarters.
  • Tilson Financial Group's Repligen position peaked at $276K in Q1 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Tilson Financial Group's 13F filing for Q1 2026, filed 29 Apr 2026.